IVIVR versus IVIVC

Dissolution Technologies

Volumn 7, Issue 3, 2000, Pages 6-8

  Polli, James E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOLUTION; IN VITRO STUDY;

EID: 84962124081     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT070300P6     Document Type: Article

References (8)

1. USP 23-NF 18; United States Pharmacopeial Convention, Inc., Rockville, MD, 1994.
2. Extended Release Solid Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations, Center for Drug Evaluation and Research, Food and Drug Administration, September, 1997.
3. J. E. Polli, J. R. Crison, and G. L. Amidon, Novel approach to the analysis of in vitro-in vivo relationships, J. Pharm. Sci. 85, 753-760 (1996).
4. E. Galia, E. Nicolaides, D. Horter, R. Lobenberg, C. Reppas, and Dressman JB, Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res. 15, 698-705 (1998).
5. Kachigan, S. K. Multivariate Statistical Analysis; Radius Press, New York, 1991.
6. J. E. Polli, G. S. Rekhi, L. L. Augsburger, and V. P. Shah, Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets, J. Pharm. Sci. 86, 690-700 (1997).
7. J. E. Polli and M. J. Ginski, Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities, Pharm. Res. 15, 47-52 (1998).
8. J. Devane and J. Butler. The impact of in vitro-in vivo relationships on product development, Pharm. Tech. 21, 146-159 (1997)